An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
ABSTRACT Influenza virus infections are a global public health problem, with a significant impact of morbidity and mortality from both annual epidemics and pandemics. The current strategy for preventing annual influenza is to develop a new vaccine each year against specific circulating virus strains...
Guardado en:
Autores principales: | Louis M. Schwartzman, Andrea L. Cathcart, Lindsey M. Pujanauski, Li Qi, John C. Kash, Jeffery K. Taubenberger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cea1cc51d5b54d1b8b118a8c21c76d8d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Contemporary Avian Influenza A Virus Subtype H1, H6, H7, H10, and H15 Hemagglutinin Genes Encode a Mammalian Virulence Factor Similar to the 1918 Pandemic Virus H1 Hemagglutinin
por: Li Qi, et al.
Publicado: (2014) -
Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.
por: Penghui Yang, et al.
Publicado: (2012) -
Influenza Viruses: Breaking All the Rules
por: Jeffery K. Taubenberger, et al.
Publicado: (2013) -
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza.
por: Nathalie Landry, et al.
Publicado: (2010) -
Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge
por: Mariana Baz, et al.
Publicado: (2015)